Discover Screener Plans Log In Sign Up
ISRG
Intuitive Surgical, Inc.
Summary
Business
Earnings Call
Valuation
Profitability
Financial Health
Intel
Yearly Return 10Y annualized return is excellent at 26.3% per year
Earnings Expectations ISRG has met or exceeded earnings expectations in most recent quarters (9/10)
Positive Strong Profitability Margins
Positive Return on Equity
Negative High Valuation Ratios
Negative Challenges in International Markets

Unlock Complete Analysis

Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.

Complete key takeaways analysis
Advanced financial metrics
Real-time insights & alerts
Start Your Premium Journey

Already have an account? Sign in

Overall, Intuitive Surgical maintains a strong business model buoyed by solid financial performance and innovative product offerings. However, challenges in international markets and margin pressures may affect future growth. The company shows promising growth prospects through continued R&D investment and market expansion, while navigating competitive pressures.

Analysis Date: January 23, 2025
Last Updated: May 29, 2025

+935%
+26.3% per year

Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.

Country US
Exchange NASDAQ
Industry Medical - Instruments & Supplies
Sector Healthcare
Market Cap $193.18B
CEO Dr. Gary S. Guthart Ph.D.

Intuitive Surgical, Inc. makes advanced robotic systems that help doctors perform surgeries with less cutting and quicker recovery for patients. Their main product, the da Vinci Surgical System, allows surgeons to do complex procedures through small openings in the body instead of large cuts. The company also provides tools and support to help hospitals use their technology effectively. Overall, Intuitive Surgical focuses on improving how surgeries are done to make them safer and easier for patients.

Streams of revenue

Instruments and Accessories: 62%
Systems: 22%
Services: 16%

Geographic Distribution

Asia: 0%
Other: 0%
Europe: 0%
United States: 0%

Estimations for reference only

Core Products

👁️
Vision Systems Surgical imaging
📚
Training Services Surgical training
🔧
Surgical Instruments Tools for surgery
🫁
Ion Endoluminal System Lung biopsy system
🤖
da Vinci Surgical System Robotic surgery system

Business Type

B2B Business to Business

Competitive Advantages

Unlock Competitive Advantages Analysis

Discover all competitive advantages and strategic moats that protect ISRG's market position.

View Premium Analysis

Key Business Risks

Unlock Complete Risk Analysis

Get comprehensive insight into all key business risks that could impact ISRG's performance.

Access Full Risk Analysis

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Graham Value Metrics

Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.

📊

Unlock Graham value analysis

Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis

✓ Intrinsic value calculations
✓ Margin of safety analysis
✓ Complete Graham criteria checklist
✓ Value investing insights
Upgrade to Premium

ROE: 15.516428357696881

ROA: None

Gross Profit Margin: 67.08625457549714

Net Profit Margin: 28.412259463677152

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Scroll horizontally to see more

About Profitability Metrics

Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.

📊

Unlock Profitability Metrics

Access detailed profitability metrics with visual gauges and benchmarks

  • • Return on Equity (ROE) analysis
  • • Return on Assets (ROA) insights
  • • Gross & Net Profit Margins
  • • Industry benchmark comparisons
Sign Up for Premium
💪

Unlock profitability strengths

Access detailed analysis of profitability strengths and positive performance indicators

Upgrade to Premium
⚠️

Unlock profitability weaknesses

Access detailed analysis of profitability weaknesses and areas of concern

Upgrade to Premium

About Financial Health Metrics

Financial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.

🏦

Unlock Financial Health Metrics

Access detailed financial health metrics with visual gauges and risk assessments

  • • Debt to Equity ratio analysis
  • • Current ratio & liquidity insights
  • • Financial risk assessments
  • • Stability benchmarks
Sign Up for Premium
🛡️

Unlock financial strengths

Access detailed analysis of financial health strengths and stability indicators

Upgrade to Premium
⚠️

Unlock financial weaknesses

Access detailed analysis of financial health weaknesses and risk factors

Upgrade to Premium

Meeting Expectations

9 /10

Higher values indicate better execution and credibility

Recent Results

🔒

Unlock earnings history

View complete earnings history and detailed performance analysis

Upgrade to Premium

EPS

1.74
Estimated
1.81
Actual
+4.02%
Difference

Revenue

$2185807506
Estimated
$2253400000
Actual
+3.09%
Difference
💪

Unlock strenghts analysis

Unlock complete business strengths analysis

Upgrade to Premium
⚠️

Unlock weaknesses analysis

Unlock complete business weaknesses analysis

Upgrade to Premium
🚀

Unlock opportunities analysis

Unlock complete future opportunities analysis

Upgrade to Premium

Unlock risk analysis

Unlock complete future risks analysis

Upgrade to Premium

Insider trading data shows purchase and sale activities by company executives and board members.

Insider Sentiment Analysis

Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.

🔍

Unlock Insider Analysis

Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights

  • • Insider buy/sell ratio analysis
  • • Total bought vs sold volumes
  • • Active insider tracking
  • • Recent trend analysis
Sign Up for Premium

ISRG Stock Analysis: Intuitive Surgical, Inc. Investment Guide

ISRG (Intuitive Surgical, Inc.) is a Healthcare company listed on NASDAQ Global Select. The stock has generated 26.3% annual returns with an overall investment score of None/100.

Overall, Intuitive Surgical maintains a strong business model buoyed by solid financial performance and innovative product offerings. However, challenges in international markets and margin pressures may affect future growth. The company shows promising growth prospects through continued R&D investment and market expansion, while navigating competitive pressures.

ISRG Key Financial Metrics

ISRG financial analysis includes comprehensive valuation ratios, profitability metrics, and financial health indicators. and profitability score of 5.0/100 with financial health rated 8.4/100.

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. makes advanced robotic systems that help doctors perform surgeries with less cutting and quicker recovery for patients. Their main product, the da Vinci Surgical System, allows surgeons to do complex procedures through small openings in the body instead of large cuts. The company also provides tools and support to help hospitals use their technology effectively. Overall, Intuitive Surgical focuses on improving how surgeries are done to make them safer and easier for patients.

ISRG Investment Recommendation

Based on our comprehensive analysis of ISRG, investors should consider the company's strong performance track record, earnings consistency (9/10 quarters beat expectations), and current valuation metrics when making investment decisions.

Healthcare Sector Analysis

ISRG operates in the Medical - Instruments & Supplies industry within the Healthcare sector. This analysis compares Intuitive Surgical, Inc. performance against industry and sector benchmarks to provide context for investment decisions.

Frequently Asked Questions about ISRG Stock

Is ISRG a good investment?

ISRG (Intuitive Surgical, Inc.) has generated 26.3% annual returns with an overall score of None/100. Overall, Intuitive Surgical maintains a strong business model buoyed by solid financial performance and innovative product offerings. However, challenges in international markets and margin pressures may affect future growth. The … Investors should consider their risk tolerance and investment goals when evaluating ISRG.

What is ISRG P/E ratio and valuation?

ISRG valuation metrics including P/E ratio, price-to-book ratio, and price-to-sales ratio are analyzed on this page with comparisons to Medical - Instruments & Supplies industry and Healthcare sector benchmarks.

Should I buy ISRG stock now?

The decision to buy ISRG stock should be based on comprehensive analysis of financial metrics, market conditions, and individual investment goals. Our analysis provides profitability score of 5.0/100, financial health score of 8.4/100, and detailed performance metrics to help inform your investment decision.

What are ISRG financial health indicators?

ISRG financial health analysis includes liquidity ratios, debt levels, cash flow metrics, and profitability indicators. The company has a financial health score of 8.4/100 based on comprehensive analysis of balance sheet strength and operational efficiency.

How does ISRG compare to competitors?

ISRG performance is benchmarked against Medical - Instruments & Supplies industry peers and Healthcare sector averages. Our analysis includes comparative valuation ratios, profitability metrics, and growth indicators to provide context for Intuitive Surgical, Inc.'s market position.

What are ISRG historical returns?

ISRG has generated 26.3% annual returns over the 10Y. Historical performance analysis includes price appreciation, dividend yields, and total shareholder returns compared to market benchmarks.

ISRG Key Investment Metrics Summary

  • Annual Return: 26.3%
  • Profitability Score: 5.0/100
  • Financial Health Score: 8.4/100
  • Growth Score: 6.374474268425626/100
  • Earnings Beat Rate: 9/10 quarters
  • Sector: Healthcare
  • Industry: Medical - Instruments & Supplies
  • Exchange: NASDAQ Global Select
  • Market Cap: 193180804230

ISRG Investment Thesis

Intuitive Surgical, Inc. (ISRG) represents an excellent investment opportunity in the Healthcare sector. With an overall score of None/100, the company demonstrates areas for financial improvement.

Investment Strengths

  • Strong Profitability Margins
  • Return on Equity
  • Operating Profit Margin
  • No Debt Levels
  • Strong Liquidity Ratios
  • Strong Financial Performance
  • Innovative Product Launches
  • Market Expansion and Acquisitions
  • Growth in Procedure Volume
  • Investment in R&D
  • Expansion into New Indications

Investment Risks

  • High Valuation Ratios
  • Challenges in International Markets
  • Margin Pressures
  • Competitive Landscape
  • Potential Tariffs Impact
Home Screener Search Profile

During the beta period, we're currently displaying stocks from the S&P 500 index only. More stocks will be added soon.

Loading...